Cui Jiuwei1, Zhuo Wenlei2, Huang Lan3, Xu Chuan4, Sun Xuejun5, Liu Yudi1, Tian Huimin1, Liang Tingting1, Chen Ping6, Chen Bo7, Liu Qiuyan8, Ying Jie’er9, Li Ningning10, Zhang Anping11, Yu Yang12, Zhou Zhifeng13, Wu Xiufeng14, Guo Xiaoling15, Zhao Lingdi16, Zhai Junya17, Yang Chaoyang18, Yang Jing19, Li Xia20, Li Yong21, Liu Guoqing22, Sun Guorui23, Han Zhenguo24, Yang Xiaojun25, Cui Wei26, Chen Feng27, Wu Yu28, Liu Liang29, Li Guixin30, Dai Jing31, Zhao Zheng32, Zhao Bing33, Kuang Xiaoyan34, Qin Jianyong35, Zhou Xin36, Tan Yehui1, Shi Hanping37; Chinese Society of Nutritional Oncology (CSNO)
1.Department of Oncology Center, the First Hospital of Jilin University, Changchun 130021, Jilin, China; 2.Department of Oncology, Xinqiao Hospital of Army Medical University, Chongqing 404100, China; 3.Biological Cell Therapy Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, China; 4.Cancer Diagnosis and Treatment Center, General Hospital of Chengdu Military Region, Chengdu 610083, Sichuan, China; 5.Department of General Surgery, the First Affiliated Hospital of Xi′an Jiaotong University, Xi′an 710061, Shaanxi, China; 6.Department of Oncology Center, Cancer Hospital of General Hospital of Ningxia Medical University, Yinchuan 750003, Ningxia, China; 7.Department of Gastroenterology, the First Affiliated Hospital of Anhui Medical University, Hefei 230022, Anhui, China; 8.Institute of Immunology, the Second Military Medical University, Shanghai 200433, China; 9.Department of Gastroenterology and Oncology, Zhejiang Cancer Hospital, Hangzhou 310022, Zhejiang, China; 10 .Precision Medicine Research Center, the Seventh Affiliated Hospital of Sun Yat Sen University, Shenzhen 518034, Guangdong, China; 11.Department of Gastroenterology, Daping Hospital, Army Medical University, Chongqing 400042, China; 12 .Department of Oncology Center, Xuzhou Central Hospital, Xuzhou 221009, Jiangsu, China; 13.Department of Oncoimmunology, Fujian Cancer Hospital, Fuzhou 350014, Fujian, China; 14.Department of Galactophore Surgery, Fujian Cancer Hospital, Fuzhou 350014, Fujian, China; 15.Department of Hematology, the Second Hospital of Hebei Medical University, Shijiazhuang 050003, Hebei, China; 16.Department of Biological Immunotherapy,Henan Cancer Hospital, Zhengzhou 450008, Henan, China; 17.Department of Clinical Nutrition, Henan Cancer Hospital, Zhengzhou 450008, Henan, China; 18.Department of Oncology, Cancer Hospital of Harbin Medical University, Harbin 150001, Heilongjiang, China; 19.Department of Gastroenterology, the Third Affiliated Hospital of Suzhou University, Changzhou 213003, Jiangsu, China; 20 .Department of Radiotherapy, Liaoning Cancer Hospital, Shenyang 110042, Liaoning, China; 21.Department of Tumor Chemoradiotherapy, the First Affiliated Hospital of Nanchang Medical University, Nanchang 330006, Jiangxi, China; 22.Department of Oncology Surgery, Qinghai Provincial People’s Hospital, Xining 810007, Qinghai, China; 23.Department of Gastroenterology, Qilu Hospital of Shandong University, Jinan 250012, Shandong, China; 24.Department of General Surgery, Shanxi Bethune Hospital, Taiyuan 030032, Shanxi, China; 25.Neuroscience Center, Shantou University Medical College, Shantou 515041, Guangdong, China; 26.School of Life Sciences and Life Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, Liaoning,China; 27.Neurotumor Comprehensive Treatment Center, Beijing Shijitan Hospital, Beijing 100038, China; 28.Department of Hepatobiliary Surgery, Tianjin Hospital of ITCWN Nankai Hospital, Tianjin 300193, China; 29.Department of Biotherapy, Tianjin Medical University Cancer Institute & Hospital, Tianjin 300060, China; 30.Department of Oncology, Affiliated Hospital of Weifang Medical College, Weifang 261031, Shandong, China; 31.Cancer Radiotherapy and Chemotherapy Department, Zhongnan Hospital of Wuhan University, Wuhan 430071, Hubei, China; 32.Department of Oncology Center, Shaanxi Cancer Hospital Affiliated to Xi′an Jiaotong University, Xi′an 710061, Shaanxi, China; 33.Day Ward, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi 830011, Xinjiang, China; 34.Office of Academic Research, Zunyi Medical and Pharmacutical College, Zunyi, 563006, Guizhou, China; 35.Department of Oncology, Liwan Hospital of the Third Affiliated Hospital of Guangzhou Medical University, Guangzhou 510175, Guangdong, China; 36.Clinical Research Center, Xinhua Hospital Affiliated to Shanghai Jiaotong University of Medicine, Shanghai 200092, China; 37.Department of Gastrointestinal Surgery, Beijing Shijitan Hospital, Capital Medical University/the Ninth Clinical Medical College of Peking University, Beijing 100038, China
Abstract:Immunonutrition is a kind of targeted nutrition therapy that plays a significant role in the regulation of immune, metabolic and inflammatory changes during tumor development. It is an important branch of cancer nutrition therapy and has been widely used in many fields, such as surgery, radiotherapy and chemotherapy, and the treatment of cancer complications. However, although several international nutrition guidelines have addressed the use of immunonutrients in the clinical treatment of cancers, most of which are only scattered parts of the guidelines and lack of systematic collation and induction, and several relevant contents in the guidelines and clinical research results are still controversial. In addition, the deficient understanding of the specific mechanism and curative effect of tumor immune nutrients currently has further led to the limitation and non-standardization of immunonutrition in clinical practice. Therefore, in order to better guide clinical practice, through the collection and collation of critical clinical research results and authoritative guidelines published in recent years under the guidance of evidence-based medicine, experts of the Cancer Nutrition Committee of Chinese Anti Cancer Association have systematically analyzed and repeatedly proofread diverse research evidence, and put forward strict recommendations according to the evidence and recommendation levels in the rating criteria of Oxford Centre for Evidence-based Medicine, with a view to update the 2016 cancer immunonutrition guideline and provide a reference and basis for future standardized immunonutrition therapy for clinical cancer patients.
崔久嵬,卓文磊,黄岚,许川,孙学军,刘玉迪,田慧敏,梁婷婷,陈萍,陈博,刘秋燕,应杰儿,李宁宁,张安平,于洋,周智峰,吴秀凤,郭晓玲,赵玲娣,翟军亚,杨朝阳,杨. 肿瘤免疫营养治疗指南[J]. 肿瘤代谢与营养电子杂志, 2020, 7(2): 160-168.
Cui Jiuwei, Zhuo Wenlei, Huang Lan, Xu Chuan, Sun Xuejun, Liu Yudi, Tian Huimin, Liang Tingting, Chen Ping, Chen Bo, Liu Qiuyan, Ying Jie’er, Li Ningning, Zhang Anping, Yu Yang, Zhou Zhifeng, Wu Xiufe. Guideline on cancer immunonutrition. Electron J Metab Nutr Cancer, 2020, 7(2): 160-168.
1.DALY J M, LIEBERMAN M D, GOLDFINE J, et al. Enteral nutrition with supplemental arginine, RNA, and omega-3 fatty acids in patients after operation: immunologic, metabolic, and clinical outcome[J]. Surgery, 1992, 112(1): 56-67.
2.MARIMUTHU K, VARADHAN K K, LJUNGQVIST O, et al. A meta-analysis of the effect of combinations of immune modulating nutrients on outcome in patients undergoing major open gastrointestinal surgery[J]. Annals of surgery, 2012, 255(6): 1060-1068.
3.DROVER J W, DHALIWAL R, WEITZEL L, et al. Perioperative use of arginine-supplemented diets: a systematic review of the evidence[J]. J Am Coll Surg, 2011, 212(3): 385-399.
4.SCARPA M, KOTSAFTI A, FASSAN M, et al. Immunonutrition before esophagectomy: Impact on immune surveillance mechanisms[J]. Tumour Biol, 2017, 39(10): 1010428317728683.
5.PEKER K D, OZKANLI S S, AKYUZ C, et al. Preoperative immunonutrition regulates tumor infiltrative lymphocytes and increases tumor angiogenesis in gastric cancer patients[J]. Arch Med Sci,2017;13:1365-1372.
6.RUSSELL K, ZHANG H G, GILLANDERS L K, et al. Preoperative immunonutrition in patients undergoing liver resection: A prospective randomized trial[J]. World journal of gastroenterology, 2019, 11(3): 305-317.
7.LUO Z, WANG J, ZHANG Z, et al. Efficacy of early enteral immunonutrition on immune function and clinical outcome for postoperative patients with gastrointestinal cancer[J]. JPEN J Parenter Enteral Nutr, 2018, 42(4): 758-765.
8.CHENG Y, ZHANG J, ZHANG L, et al. Enteral immunonutrition versus enteral nutrition for gastric cancer patients undergoing a total gastrectomy: a systematic review and meta-analysis[J]. Bmc Gastroenterology, 2018, 18(1): 11.
9.LI K, XU Y, HU Y, et al. Effect of enteral immunonutrition on immune, inflammatory markers and nutritional status in gastric cancer patients undergoing gastrectomy: a randomized double-blinded controlled trial[J]. J Invest Surg, 2019, 19: 1-10.
10.SCISLO L, PACH R, NOWAK A, et al. The impact of postoperative enteral immunonutrition on postoperative complications and survival in gastric cancer patients-randomized clinical trial[J]. Nutr Cancer, 2018, 70(3): 453-459.
11.MCKAY B P, LARDER A L, LAM V. Pre-Operative vs. peri-operative nutrition supplementation in hepatic resection for cancer: a systematic review[J]. Nutr Cancer, 2019, 71(2): 179-98.
12.KANEKIYO S, TAKEDA S, IIDA M, et al. Efficacy of perioperative immunonutrition in esophageal cancer patients undergoing esophagectomy[J]. Nutrition, 2019, 59: 96-102.
13.LASSEN K, COOLSEN MME, SLIM K, et al. Guidelines for perioperative care for pancreaticoduodenectomy: Enhanced Recovery After Surgery (ERAS) Society recommendations[J]. Clin Nutr, 2012, 31(6): 817-830.
14.GUSTAFSSON U O, SCOTT M J, SCHWENK W, et al. Guidelines for perioperative care in elective colonic surgery: Enhanced Recovery After Surgery (ERAS) Society recommendations[J]. Clin Nutr, 2012, 31(6): 783-800.
15.ARENDS J, BACHMANN P, BARACOS V, et al. ESPEN guidelines on nutrition in cancer patients[J]. Clin Nutr, 2017, 36(1): 11-48.
16.WEI J, CHEN W, ZHU M, et al. Guidelines for parenteral and enteral nutrition support in geriatric patients in China[J]. Asia Pac J Clin Nutr, 2015, 24(2): 336-246.
17.ROWAN N R, JOHNSON J T, FRATANGELO C E, et al. Utility of a perioperative nutritional intervention on postoperative outcomes in high-risk head & neck cancer patients[J]. Oral Oncol, 2016, 54: 42-46.
18.AEBERHARD C, MAYER C, MEYER S, et al. Effect of preoperative immunonutrition on postoperative short-term outcomes of patients with head and neck squamous cell carcinoma[J]. Head neck, 2018, 40(5): 1057-1067.
19.BARAJAS-GALINDO D E, VIDAL-CASARIEGO A, PINTOR-DE LA MAZA B, et al. Postoperative enteral immunonutrition in head and neck cancer patients: Impact on clinical outcomes[J]. Endocrinol Diabetes Nutr, 2020, 67(1): 13-19.
20.MUELLER S A, MAYER C, BOJAXHIU B, et al. Effect of preoperative immunonutrition on complications after salvage surgery in head and neck cancer[J]. J Otolaryngol Head Neck Surg, 2019, 48(1): 25.
21.WEIMANN A, BRAGA M, HARSANYI L, et al. ESPEN guidelines on enteral nutrition: surgery including organ transplantation[J]. Clin Nutr, 2006, 25(2): 224-244.
22.HOWES N, ATKINSON C, THOMAS S, et al. Immunonutrition for patients undergoing surgery for head and neck cancer[J]. Cochrane Database Syst Rev, 2018, 8: CD010954.
23.HAMILTON-REEVES J M, STANLEY A, BECHTEL M D, et al. Perioperative immunonutrition modulates inflammatory response after radical cystectomy: results of a pilot randomized controlled clinical trial[J]. J Urol, 2018, 200(2): 292-301.
24.KHEMISSA F, MINEUR L, AMSELLEM C, et al. A phase Ⅲ study evaluating oral glutamine and transforming growth factor-beta 2 on chemotherapy-induced toxicity in patients with digestive neoplasm[J]. Dig Liver Dis, 2016, 48(3): 327-332.
25.HAN Y, ZHANG F, WANG J, et al. Application of glutamine-enriched nutrition therapy in childhood acute lymphoblastic leukemia[J]. Nutr J, 2016, 15(1): 65.
26.WANG J, LI Y, QI Y. Effect of glutamine-enriched nutritional support on intestinal mucosal barrier function, MMP-2, MMP-9 and immune function in patients with advanced gastric cancer during perioperative chemotherapy[J]. Oncology Lett, 2017, 14(3): 3606-3610.
27.SANDS S, LADAS EJ, KELLY K M, et al. Glutamine for the treatment of vincristine-induced neuropathy in children and adolescents with cancer[J]. Support care cancer, 2017, 25(3): 701-708.
28.MAZZUCA F, ROBERTO M, ARRIVI G, et al. Clinical impact of highly purified, whey proteins in patients affected with colorectal cancer undergoing chemotherapy: preliminary results of a placebo-controlled study[J]. Integr Cancer Ther, 2019, 18: 1534735419866920.
29.LOPEZ-VAQUERO D, GUTIERREZ-BAYARD L, RODRIGUEZ-RUIZ J A, et al. Double-blind randomized study of oral glutamine on the management of radio/chemotherapy-induced mucositis and dermatitis in head and neck cancer[J]. Mol Clin Oncol, 2017, 6(6): 931-936.
30.ROTOVNIK KOZJEK N, KOMPAN L, AGAR T, et al. Influence of enteral glutamine on inflammatory and hormonal response in patients with rectal cancer during preoperative radiochemotherapy[J]. Eur J Clin Nutr, 2017, 71(5): 671-673.
31.LINN Y H, THU K K, WIN N H H. Effect of probiotics for the prevention of acute radiation-induced diarrhoea among cervical cancer patients: a randomized double-blind placebo-controlled study[J]. Probiotics Antimicrob Proteins, 2019, 11(2): 638-647.
32.PETERSON D E, BOERS-DOETS C B, BENSADOUN R J, et al. Management of oral and gastrointestinal mucosal injury: ESMO clinical practice guidelines for diagnosis, treatment, and follow-up[J]. Ann Oncol, 2015, 26 Suppl 5: v139-v51.
33.THOMPSON K L, ELLIOTT L, FUCHS-TARLOVSKY V, et al. Oncology evidence-based nutrition practice guideline for adults[J]. J Acad Nutr Diet, 2017, 117(2): 297-310.e47.
34.IYAMA S, SATO T, TATSUMI H, et al. Efficacy of enteral supplementation enriched with glutamine, fiber, and oligosaccharide on mucosal injury following hematopoietic stem cell transplantation[J]. Case Rep Oncol, 2014, 7(3): 692-699.
35.KOTA H, CHAMBERLAIN R S. Immunonutrition is associated with a decreased incidence of graft-versus-host disease in bone marrow transplant recipients: a meta-analysis[J]. JPEN J Parenter Enteral Nutr, 2017, 41(8): 1286-1292.
36.BOZZETTI F, ARENDS J, LUNDHOLM K, et al. ESPEN guidelines on parenteral nutrition: non-surgical oncology[J]. Clin Nutr, 2009, 28(4): 445-454.
37.CHO Y K, HONG S Y, JEON S J, et al. Efficacy of parenteral glutamine supplementation in adult hematopoietic stem cell transplantation patients[J]. Blood research, 2019, 54(1): 23-30.
38.SHIRAI Y, OKUGAWA Y, HISHIDA A, et al. Fish oil-enriched nutrition combined with systemic chemotherapy for gastrointestinal cancer patients with cancer cachexia[J]. Sci Rep, 2017, 7(1): 4826.
39.KITAGAWA M, HAJI S, AMAGAI T. Elevated serum AA/EPA ratio as a predictor of skeletal muscle depletion in cachexic patients with advanced gastro-intestinal cancers[J]. In Vivo, 2017, 31(5): 1003-1009.
40.MOCHAMA T, CUHLS H, MARINOVA M, et al. A systematic review on the role of vitamins, minerals, proteins, and other supplements for the treatment of cachexia in cancer: a European Palliative Care Research Centre cachexia project[J]. J cachexia sarcopenia muscle, 2016.
41.濱口哲也,三木誓雄.がん患者の代謝と栄養[J].日本静脈経腸栄養学会雑誌, 2015, 30(4): 911-916.
42.NYGREN J, THACKER J, CARLI F, et al. Guidelines for perioperative care in elective rectal/pelvic surgery: Enhanced Recovery After Surgery (ERAS) Society recommendations[J]. Clin Nutr, 2012, 31(6): 801-816.
43.MCCLAVE S A, MARTINDALE R G, VANEK V W, et al. Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.)[J]. JPEN J Parenter Enteral Nutr, 2009, 33(3): 277-316.
44.HEYLAND D K, DHALIWAL R, DROVER J W, et al. Canadian clinical practice guidelines for nutrition support in mechanically ventilated, critically ill adult patients[J]. JPEN J Parenter Enteral Nutr, 2003, 27(5): 355-373.